vancomycin has been researched along with Renal Insufficiency in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (10.00) | 18.2507 |
2000's | 9 (11.25) | 29.6817 |
2010's | 47 (58.75) | 24.3611 |
2020's | 16 (20.00) | 2.80 |
Authors | Studies |
---|---|
Hayakawa, M; Imai, S; Mikami, R; Sugawara, M; Takekuma, Y | 1 |
Ambreen, G; Hussain, K; Ikram, R; Khan, M; Khan, WA; Naz, F; Rathi, M; Rauf, S; Salat, MS | 1 |
Babić, G; Krečak, I; Skelin, M | 1 |
Bolisetty, S; Chiletti, R; Cranswick, N; Curtis, N; Duffull, S; Gardiner, K; Gwee, A; Hunt, R; Lai, T; Malhotra, A; McMullan, B; Mehta, B; Michalowski, J; Popat, H; Ward, M; Wilkins, AL; Zhu, X | 1 |
Liu, X; Tian, Z; Wang, M | 1 |
Alduhami, AA; ALharbi, A; Altowayan, WM; Mobark, MA; Rabbani, SI | 1 |
Benefield, RJ; Certain, LK; McDonald, J; Newman, M; Tritle, B | 1 |
Day, RO; Musgrave, K; Penny, M; Roberts, DM; Sevastos, J; Stefani, M | 1 |
Dong, Y; Du, Q; Liu, Y; Sun, D; Wang, T; You, H; Zhang, D; Zhang, T; Zhang, Y | 1 |
Chambers, ST; Chin, PKL; Dalton, SC; Drennan, PG; Gardiner, SJ; Long, M; Metcalf, SCL; Yi, M | 1 |
Ashraf, S; Ijaz, F; Malkani, N; Mumtaz, S; Naeem, A; Sohail, MI | 1 |
Driemeyer, C; Pasqualotto, AC; Poloni, JAT; Ulysséa, LMT | 1 |
Dalton, B; Jorgensen, SCJ; Stewart, JJ | 1 |
Enoki, Y; Fujii, S; Hamada, Y; Kimura, T; Kojima, N; Matsumoto, K; Mizukami, Y; Moriyama, H; Oda, K; Osa, S; Taguchi, K; Takahashi, Y; Takesue, Y; Tashiro, S; Tsutsuura, M | 1 |
Khalili, H; Rahmani, H | 1 |
Asai, N; Hagihara, M; Kato, H; Koizumi, Y; Mikamo, H; Okudaira, M; Yamagishi, Y | 1 |
Kasai, K; Okabe, M; Yokoo, T | 1 |
Alavi Darazam, I; Ayoubian, Z; Sajadi, MM; Shokouhi, S | 1 |
de Moya, MA; Elshaboury, RH; Lin, H; Newman, K; Sin, JH; Yeh, DD | 1 |
Aoki, Y; Bito, S; Hirose, S; Kamimura, Y; Kimura, Y; Mori, N | 1 |
de Alarcón González, A; Domínguez, F; Fariñas, MC; Fernández-Cruz, A; Gálvez-Acebal, J; Gutiérrez-Cuadra, M; HidalgoTenorio, C; Miró, JM; Montejo, JM; Muñoz Serrano, A; Muñoz, P; Ramos-Martínez, A; Ruiz-Morales, J; Sousa-Regueiro, D; Valerio, M | 1 |
Baumgartner, C; Child, J; Hurst, AL; MacBrayne, CE | 1 |
Fresco, P; Gonçalves, J; Hahn, SR; Monteiro, JF | 1 |
Couet, W; Gobin, P; Lauda, M; Le Moal, G; Marchand, S; Roblot, F | 1 |
Cui, E; Eells, SJ; Huang, SS; McKinnell, JA; Miller, LG | 1 |
Heath, CH; Ingram, PR; Manning, L; Norton, K | 1 |
Davies, SW; Guidry, CA; Hranjec, T; Petroze, RT; Sawyer, RG | 1 |
Amaya-Villar, R; Artero-González, ML; Bautista-Paloma, J; Corcia-Palomo, Y; Espejo-Gutiérrez de Tena, E; Garnacho-Montero, J; Gutiérrez-Pizarraya, A | 1 |
Bosch, K; Esterly, JS; McLaughlin, MM; Postelnick, MJ; Rhodes, NJ; Scheetz, MH | 1 |
Fujii, S; Kunimoto, Y; Makino, S; Miyamoto, A; Nakata, H; Noda, N; Sakurai, K; Takahashi, S | 1 |
Adeli, K; Colantonio, DA; Helldén, A; Koren, G; Neuman, G; Nulman, I | 1 |
Golan, Y; Holcroft, C; Snydman, DR; Weston, A | 1 |
Chastre, J; Gao, X; Haider, S; Li, JZ; Myers, DE; Niederman, MS; Solem, CT; Stephens, JM; Wan, Y | 1 |
Eliakim-Raz, N; Goldberg, E; Leibovici, L; Steinmetz, T; Yahav, D | 1 |
Amankwah, EK; Beckman, JM; Perlman, SA; Tetreault, LL; Tuite, GF | 1 |
Ammann, H; Bernier-Jean, A; Bouchard, J; Brunette, V; Lavergne, V; Paquette, F; Pichette, V; Troyanov, S | 1 |
Chen, Y; Gao, P; Hu, J; Shen, X; Wang, Y; Xu, H; Xu, Q; Zhang, H; Zhang, L | 1 |
Davies, SW; Dietch, ZC; Efird, JT; Guidry, CA; Sawyer, RG; Shah, PM; Willis, RN | 1 |
Chen, Y; Gao, X; Haider, S; Li, Q; Liu, S; Wan, Y | 1 |
Al-Tawfiq, JA; Homoud, A; Momattin, H; Zogheib, M | 1 |
Dong, H; Zhong, Y | 1 |
Echeverría-Esnal, D; Grau, S; Marín-Casino, M; Retamero, A | 1 |
Bin, C; Rello, J | 1 |
Carreno, JJ; Davis, SL; Divine, G; Kenney, RM; Vazquez, JA | 1 |
Koch, G; Pfister, M; Schropp, J | 1 |
Dinh, A; Le Monnier, A; Tilleul, P; Watt, M | 1 |
Crawford, BS; Doran, JJ; Largen, RF; Walton, T | 1 |
De Vriese, AS; Vandecasteele, SJ | 1 |
Furlanut, M; Pea, F; Viale, P | 1 |
Hermsen, ED; Kalil, AC; Murthy, MH; Neto, FK; Rupp, ME; Sun, J | 1 |
Beringer, P; Joo, J; Tse, E; Wong-Beringer, A | 1 |
Chapnick, E; Kupfer, Y; Pagala, M; Rao, S; Tessler, S | 1 |
Bogard, KN; Erwin, MW; Fuller, PD; Olsen, KM; Peterson, NT; Plumb, TJ | 1 |
Álvarez Lerma, F; García Simón, M; González Pérez, MI; Rodriguez Colomo, O; Sirvent, JM | 1 |
Garg, S; Marrie, TJ; Tyrrell, GJ; Vanderkooi, OG | 1 |
Lomaestro, BM | 1 |
Cobos, N; Fernandez, J; Martínez, JA; Mensa, J; Mohamad, AM; Morata, L; Soriano, A; Sterzik, H | 1 |
Aubron, C; Cheng, AC; Corallo, CE; Dooley, MJ; Nunn, MO | 1 |
Davis, SL; Delgado, G; Falcione, B; Kullar, R; Leonard, SN; Pogue, JM; Rybak, MJ; Wahby, KA | 1 |
Cataldo, MA; Grilli, E; Pea, F; Petrosillo, N; Tacconelli, E | 1 |
Bauer, MP; Dale, AP; Fawley, WN; Gerding, DN; Gorbach, SL; Hensgens, MP; Kuijper, EJ; Miller, MA; Wilcox, MH | 1 |
Gerónimo-Pardo, M; Lluch, OF | 1 |
Ikeuchi, H; Ishihara, M; Nakajima, K; Takahashi, Y; Takesue, Y; Takubo, S; Tsuchida, T; Uchino, M | 1 |
DiMondi, VP; Rafferty, K | 1 |
Ahland, R; Bär, W; Grosch, H; Krülls-Münch, J | 1 |
Allen, SE; Mercier, RC; Pai, MP | 1 |
Kasiwong, S; Klansuwan, N; Ratanajamit, C; Wangsiripaisan, A | 1 |
Hidayat, LK; Hsu, DI; Quist, R; Shriner, KA; Wong-Beringer, A | 1 |
Tobias, JD | 1 |
Kimura, T; Kokubun, H; Yago, K | 1 |
Copa, AK; Welty, TE | 1 |
Azar, RM; Chow, AW | 1 |
Adams, DJ; Saunders, NJ; Want, SV | 1 |
Sztukowski, B | 1 |
Brouwer, KL; Cross, RE; Dupuis, RE; Peckman, HJ; Sawyer, WT | 1 |
Arnow, PM; Bruce, DS; Cronin, DC; Grewal, H; Lissoos, T; Loss, GE; Mead, J; Millis, JM; Newell, KA; Schiano, T; Thistlethwaite, JR; Woodle, ES | 1 |
Callen, JP; Klein, PA | 1 |
Lehrer, M; Meenan, G; Smith, C; Sym, D | 1 |
Andremont, A; Boutan-Laroze, A; Culine, S; Droz, JP; Kattan, J; Ribrag, V | 1 |
Camacho, MC; Codina, C; López, MC; Ribas, J | 1 |
18 review(s) available for vancomycin and Renal Insufficiency
Article | Year |
---|---|
A 600 mg of fixed-dose linezolid in renally impaired patients versus 15 mg/kg intermittent dose-optimized vancomycin in renally non-impaired patients: A single centre retrospective analysis for adult patients with hospital-acquired pneumonia due to methic
Topics: Adult; Anti-Bacterial Agents; Creatinine; Cross Infection; Healthcare-Associated Pneumonia; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2023 |
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Outpatients; Patient Safety; Renal Insufficiency; Retrospective Studies; Vancomycin | 2023 |
The optimal trough-guided monitoring of vancomycin in children: Systematic review and meta-analyses.
Topics: Anti-Bacterial Agents; Child; Humans; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Renal Insufficiency; Retrospective Studies; Vancomycin | 2021 |
Prevention of Vancomycin-Induced Nephrotoxicity; An Updated Review of Clinical and Preclinical Studies.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Humans; Kidney Diseases; Renal Insufficiency; Silymarin; Vancomycin | 2022 |
Systematic review and meta-analysis to explore optimal therapeutic range of vancomycin trough level for infected paediatric patients with Gram-positive pathogens to reduce mortality and nephrotoxicity risk.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Renal Insufficiency; Vancomycin | 2021 |
A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission.
Topics: Carrier State; Clostridioides difficile; Diabetes Mellitus; Drug Resistance, Bacterial; Enterococcus; Enterocolitis, Pseudomembranous; Heart Failure; Humans; Immunosuppression Therapy; Intensive Care Units; Lung Diseases; Methicillin-Resistant Staphylococcus aureus; Nursing Homes; Patient Admission; Renal Insufficiency; Risk Factors; Staphylococcal Infections; Vancomycin | 2013 |
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Renal Insufficiency; Serum; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
Response to: 'Continuous versus intermittent infusion of vancomycin in adult patients: a systematic review and meta-analysis'.
Topics: Adult; Anti-Bacterial Agents; Humans; Infusions, Intravenous; Renal Insufficiency; Treatment Outcome; Vancomycin | 2016 |
Recent changes in vancomycin use in renal failure.
Topics: Humans; Kidney Failure, Chronic; Kidney Function Tests; Renal Dialysis; Renal Insufficiency; Renal Insufficiency, Chronic; Staphylococcal Infections; Staphylococcus; Vancomycin; Vancomycin Resistance | 2010 |
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Education, Medical, Continuing; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Randomized Controlled Trials as Topic; Renal Insufficiency; Teicoplanin; Thrombocytopenia; Vancomycin | 2010 |
Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Renal Insufficiency; Risk Assessment; Staphylococcal Infections; Vancomycin | 2011 |
Antibiotic dosing during sustained low-efficiency dialysis: special considerations in adult critically ill patients.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Critical Care; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Linezolid; Oxazolidinones; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Renal Insufficiency; Vancomycin | 2011 |
Vancomycin dosing and monitoring 2 years after the guidelines.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Drug Administration Routes; Drug Administration Schedule; Drug Dosage Calculations; Humans; Kidney; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Practice Guidelines as Topic; Renal Insufficiency; Staphylococcal Infections; Treatment Failure; Vancomycin | 2011 |
Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Renal Insufficiency; Vancomycin | 2012 |
Review of continuous-infusion vancomycin.
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Evidence-Based Medicine; Humans; Infusions, Intravenous; Methicillin-Resistant Staphylococcus aureus; Renal Insufficiency; Severity of Illness Index; Staphylococcal Infections; Vancomycin | 2013 |
[Appropriate usage of antibiotics by therapeutic drug monitoring].
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Body Weight; Dibekacin; Drug Administration Schedule; Drug Monitoring; Extracellular Fluid; Humans; Infant, Newborn; Kidney; Patient Care Team; Renal Dialysis; Renal Insufficiency; Teicoplanin; Vancomycin | 2007 |
Glycopeptides and nephrotoxicity.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Drug Monitoring; Humans; Renal Insufficiency; Teicoplanin; Vancomycin | 1994 |
Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency.
Topics: Aged; Anti-Bacterial Agents; Autoimmune Diseases; Biopsy; Humans; Immunoglobulin A; Male; Renal Insufficiency; Skin; Skin Diseases, Vesiculobullous; Substance Withdrawal Syndrome; Time Factors; Vancomycin | 2000 |
5 trial(s) available for vancomycin and Renal Insufficiency
Article | Year |
---|---|
Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Drug Costs; Female; Health Resources; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Renal Dialysis; Renal Insufficiency; Treatment Outcome; Vancomycin | 2014 |
Economic evaluation among Chinese patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus and treated with linezolid or vancomycin: a secondary, post-hoc analysis based on a Phase 4 clinical trial study.
Topics: Adult; Aged; Anti-Bacterial Agents; China; Comorbidity; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Female; Health Services; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Models, Econometric; Pneumonia, Bacterial; Renal Insufficiency; Severity of Illness Index; Socioeconomic Factors; Staphylococcal Infections; Vancomycin | 2016 |
Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT).
Topics: Academic Medical Centers; Acute Kidney Injury; Aged; Anti-Bacterial Agents; Drug Substitution; Female; Humans; Incidence; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Risk Factors; Vancomycin | 2017 |
Systemic absorption of oral vancomycin in patients with Clostridium difficile infection.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Immunoassay; Intestinal Absorption; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Vancomycin | 2011 |
Vancomycin serum concentrations in patients with renal dysfunction: a comparison of fluorescence polarization immunoassay and the enzyme-multiplied immunoassay technique.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Biological Availability; Drug Monitoring; Enzyme Multiplied Immunoassay Technique; Female; Fluorescence Polarization Immunoassay; Humans; Male; Metabolic Clearance Rate; Middle Aged; Renal Insufficiency; Vancomycin | 1996 |
57 other study(ies) available for vancomycin and Renal Insufficiency
Article | Year |
---|---|
Clinical applicability of urinary creatinine clearance for determining the initial dose of vancomycin in critically ill patients.
Topics: Anti-Bacterial Agents; Creatinine; Critical Illness; Humans; Kidney; Renal Insufficiency; Vancomycin | 2022 |
Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible.
Topics: Anti-Bacterial Agents; Area Under Curve; Child; Creatinine; Drug-Related Side Effects and Adverse Reactions; Humans; Renal Insufficiency; Retrospective Studies; Vancomycin | 2022 |
Scurvy.
Topics: Anemia; Anticoagulants; Ascorbic Acid; Ascorbic Acid Deficiency; C-Reactive Protein; Colistin; Contracture; Fatigue; Fibrinogen; Humans; Linezolid; Male; Middle Aged; Prothrombin; Renal Insufficiency; Scurvy; Serum Albumin; Thromboplastin; Vancomycin; Vitamins | 2022 |
Individualized vancomycin dosing in infants: prospective evaluation of an online dose calculator.
Topics: Anti-Bacterial Agents; Child; Female; Gram-Positive Bacterial Infections; Humans; Infant; Male; Prospective Studies; Renal Insufficiency; Retrospective Studies; Vancomycin | 2023 |
The influence of vancomycin on renal functions, the predictors and associated factors for nephrotoxicity.
Topics: Anti-Bacterial Agents; Creatinine; Cross-Sectional Studies; Female; Humans; Kidney; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Renal Insufficiency; Retrospective Studies; Urea; Vancomycin | 2023 |
Optimizing the dosing of vancomycin in patients receiving intermittent haemodialysis with low-flux filters, and the potential impact of dosing software.
Topics: Adult; Anti-Bacterial Agents; Humans; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Vancomycin | 2023 |
Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
Topics: Aged; Anti-Bacterial Agents; Bayes Theorem; Cohort Studies; Cost-Benefit Analysis; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Economics, Pharmaceutical; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Propensity Score; Prospective Studies; Renal Insufficiency; Risk Factors; Vancomycin | 2020 |
Determinants of vancomycin nephrotoxicity when administered to outpatients as a continuous 24-hour infusion.
Topics: Aged; Anti-Bacterial Agents; Biomarkers, Pharmacological; Creatinine; Drug Monitoring; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Outpatients; Renal Insufficiency; Retrospective Studies; Risk Factors; Time Factors; Vancomycin | 2020 |
Silybum marianum (milk thistle) improves vancomycin induced nephrotoxicity by downregulating apoptosis.
Topics: Animals; Antioxidants; Apoptosis; Chlorocebus aethiops; Flavonoids; Kidney; Male; Mice; Oncogene Protein p21(ras); Oxidative Stress; Plant Extracts; Renal Insufficiency; Silybum marianum; Tumor Suppressor Protein p53; Vancomycin; Vero Cells | 2020 |
Vancomycin-induced hypokalemia: A proof-of-concept case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Hypokalemia; Potassium; Renal Insufficiency; Vancomycin | 2020 |
Vancomycin AUC-guided therapeutic drug monitoring to reduce nephrotoxicity: are we overlooking a simpler solution? Comment on: Oda K, Jono H, Nosaka K, Saito H. Reduced nephrotoxicity in vancomycin therapeutic drug monitoring guided by area under the conc
Topics: Anti-Bacterial Agents; Area Under Curve; Drug Monitoring; Humans; Kidney; Microbial Sensitivity Tests; Renal Insufficiency; Vancomycin | 2020 |
Pneumothorax Secondary to Septic Pulmonary Emboli in a Long-term Hemodialysis Patient with Psoas Abscess.
Topics: Abscess; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumothorax; Psoas Abscess; Pulmonary Embolism; Renal Dialysis; Renal Insufficiency; Treatment Outcome; Vancomycin | 2017 |
Urine Vancomycin Level as a Method for Drug Monitoring in Patients With Normal and Decreased Kidney Function.
Topics: Adult; Anti-Bacterial Agents; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Vancomycin | 2017 |
Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.
Topics: Anti-Bacterial Agents; Critical Illness; Gram-Positive Bacterial Infections; Hemofiltration; Humans; Metabolic Clearance Rate; Nomograms; Prospective Studies; Renal Insufficiency; Tertiary Care Centers; Vancomycin | 2018 |
Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case-control studies of incidence and associated risk factors.
Topics: Acid-Base Equilibrium; Acidosis, Lactic; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biomarkers; Chi-Square Distribution; Comorbidity; Female; Humans; Incidence; Lactic Acid; Linezolid; Male; Middle Aged; Odds Ratio; Prognosis; Propensity Score; Renal Insufficiency; Retrospective Studies; Risk Factors; Vancomycin | 2018 |
Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis.
Topics: Aged; Anti-Bacterial Agents; Cloxacillin; Endocarditis, Bacterial; Female; Gentamicins; Heart Failure; Heart Valve Prosthesis; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Prosthesis-Related Infections; Renal Insufficiency; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2018 |
Experience with Continuous Infusion Vancomycin Dosing in a Large Pediatric Hospital.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Female; Hospitals, Pediatric; Humans; Infusions, Intravenous; Kidney; Male; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2019 |
Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations.
Topics: Aged; Anti-Bacterial Agents; Burns; Child; Critical Illness; Drug Monitoring; Hematologic Diseases; Humans; Infant, Newborn; Models, Biological; Neurosurgical Procedures; Obesity; Renal Insufficiency; Vancomycin | 2018 |
Pharmacokinetics of daptomycin in a patient with severe renal failure not receiving dialysis.
Topics: Anti-Bacterial Agents; Daptomycin; Female; Gentamicins; Humans; Middle Aged; Renal Dialysis; Renal Insufficiency; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Risk factors for nephrotoxicity in patients receiving outpatient continuous infusions of vancomycin in an Australian tertiary hospital.
Topics: Aged; Ambulatory Care; Angiotensin Receptor Antagonists; Anti-Bacterial Agents; Australia; Cohort Studies; Drug Interactions; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Outpatients; Prevalence; Renal Insufficiency; Retrospective Studies; Risk Factors; Tertiary Care Centers; Vancomycin | 2014 |
Vancomycin and nephrotoxicity: just another myth?
Topics: Anti-Bacterial Agents; Female; Follow-Up Studies; Humans; Incidence; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2013 |
Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2013 |
Impact of vancomycin treatment duration and dose on kidney injury.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Time Factors; Vancomycin; Young Adult | 2014 |
Impact of vancomycin or linezolid therapy on development of renal dysfunction and thrombocytopenia in Japanese patients.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asian People; Drug Monitoring; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Platelet Count; Renal Insufficiency; Retrospective Studies; Thrombocytopenia; Time Factors; Vancomycin; Young Adult | 2013 |
Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children.
Topics: Adolescent; Adolescent Development; Anti-Bacterial Agents; Child; Child Development; Child, Preschool; Cohort Studies; Creatinine; Drug Dosage Calculations; Female; Glomerular Filtration Rate; Humans; Infant; Kidney; Male; Models, Biological; Ontario; Renal Elimination; Renal Insufficiency; Reproducibility of Results; Severity of Illness Index; Vancomycin | 2014 |
The efficacy of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bloodstream infection in patients with impaired renal function.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Daptomycin; Female; Glomerular Filtration Rate; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Renal Insufficiency; Retrospective Studies; Staphylococcal Infections; Tertiary Care Centers; Treatment Outcome; Vancomycin | 2014 |
Complications associated with bacitracin powder in surgical wounds.
Topics: Adolescent; Anaphylaxis; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Bacitracin; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Female; Gentamicins; Humans; Hydrocephalus; Infant; Injections, Spinal; Male; Medical Records; Powders; Renal Insufficiency; Retrospective Studies; Risk Factors; Surgical Wound Dehiscence; Surgical Wound Infection; Treatment Outcome; Vancomycin; Wound Healing | 2015 |
Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Aminoglycosides; Antineoplastic Agents; Case-Control Studies; Creatinine; Female; Gentamicins; Heart Failure; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Recovery of Function; Renal Insufficiency; Retrospective Studies; Risk Factors; Tobramycin; Treatment Outcome; Vancomycin | 2015 |
Pharmacokinetic Characteristics and Clinical Outcomes of Vancomycin in Young Children With Various Degrees of Renal Function.
Topics: Anti-Bacterial Agents; Child, Preschool; Female; Glomerular Filtration Rate; Gram-Positive Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2016 |
Top Guns: The "Maverick" and "Goose" of Empiric Therapy.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Insufficiency; Retrospective Studies; Risk Assessment; Vancomycin | 2016 |
Safety and Outcome of Pharmacy-Led Vancomycin Dosing and Monitoring.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Pharmacists; Pharmacy Service, Hospital; Quality Assurance, Health Care; Renal Insufficiency; Retrospective Studies; Safety; Treatment Outcome; Vancomycin | 2016 |
Can we guarantee less nephrotoxicity when vancomycin is administered by continuous infusion?
Topics: Anti-Bacterial Agents; Humans; Infusions, Intravenous; Renal Insufficiency; Treatment Outcome; Vancomycin | 2016 |
Cost of nosocomial pneumonia: the example of vancomycin versus linezolid-shorter stay or fewer complications?
Topics: Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Hospitalization; Humans; Length of Stay; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Quality of Life; Renal Insufficiency; Vancomycin | 2016 |
Facilitate Treatment Adjustment After Overdosing: Another Step Toward 21st-Century Medicine.
Topics: Amikacin; Anti-Bacterial Agents; Drug Overdose; Humans; Infant; Infant, Newborn; Kidney; Male; Medication Errors; Models, Biological; Pharmaceutical Preparations; Renal Insufficiency; Vancomycin | 2017 |
Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France.
Topics: Age Factors; Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Fidaxomicin; France; Hospitalization; Humans; Markov Chains; Models, Economic; Neoplasms; Randomized Controlled Trials as Topic; Recurrence; Renal Insufficiency; Severity of Illness Index; Vancomycin | 2017 |
Once-weekly vancomycin for patients receiving high-flux hemodialysis.
Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Female; Georgia; Humans; Male; Middle Aged; Renal Dialysis; Renal Insufficiency; Treatment Outcome; Vancomycin | 2008 |
Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function?
Topics: Anti-Bacterial Agents; Biological Availability; Creatinine; Critical Illness; Humans; Pneumonia, Bacterial; Renal Insufficiency; Vancomycin; Wounds and Injuries | 2010 |
Impact of administration of vancomycin or linezolid to critically ill patients with impaired renal function.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Critical Illness; Female; Gram-Positive Bacterial Infections; Humans; Kidney; Linezolid; Male; Metabolic Clearance Rate; Middle Aged; Oxazolidinones; Renal Insufficiency; Retrospective Studies; Vancomycin | 2011 |
Factors predicting mortality in invasive pneumococcal disease in adults in Alberta.
Topics: Adolescent; Adult; Alberta; Anti-Bacterial Agents; beta-Lactams; Cognition Disorders; Comorbidity; Drug Therapy, Combination; Female; Humans; Lung; Macrolides; Male; Multivariate Analysis; Pneumococcal Infections; Renal Insufficiency; Respiratory Distress Syndrome; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome; Vancomycin; Young Adult | 2011 |
Is linezolid a risk factor for Gram-negative bacillus infections in intensive care unit patients? A comparative study with vancomycin.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Comorbidity; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Renal Insufficiency; Retrospective Studies; Risk Factors; Vancomycin | 2011 |
Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug Monitoring; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Models, Biological; Multiple Organ Failure; Obesity; Prospective Studies; Renal Insufficiency; Severity of Illness Index; Software; Vancomycin | 2011 |
Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
Topics: Aged; Anti-Bacterial Agents; Creatinine; Drug Dosage Calculations; Drug Monitoring; Female; Hospitals, Teaching; Humans; Male; Middle Aged; Nomograms; Practice Guidelines as Topic; Prospective Studies; Renal Insufficiency; Severity of Illness Index; Vancomycin | 2011 |
Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Confidence Intervals; Creatine; Fever; Fidaxomicin; Humans; Leukocyte Count; Leukocytosis; Odds Ratio; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Renal Insufficiency; ROC Curve; Severity of Illness Index; Time Factors; Treatment Failure; Vancomycin | 2012 |
Comments to Ocampos-Martinez et al. on one of the definitions of kidney failure, and on how to reduce the delay in reaching desired plasma concentrations of vancomycin.
Topics: Anti-Bacterial Agents; Humans; Male; Middle Aged; Plasma; Renal Insufficiency; Terminology as Topic; Vancomycin | 2012 |
Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin.
Topics: Adult; Aged; Analysis of Variance; Anti-Bacterial Agents; Bacterial Infections; Drug Monitoring; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prospective Studies; Renal Insufficiency; Risk Factors; Staphylococcal Infections; Time Factors; Vancomycin | 2013 |
[Antibiotic treatment of device-associated endocarditis with fosfomycin and vancomycin in patients with renal insufficiency].
Topics: Adult; Aged; Anti-Bacterial Agents; Defibrillators, Implantable; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Fosfomycin; Heart Valve Prosthesis; Humans; Male; Middle Aged; Pacemaker, Artificial; Prosthesis-Related Infections; Renal Insufficiency; Vancomycin | 2005 |
Using vancomycin concentrations for dosing daptomycin in a morbidly obese patient with renal insufficiency.
Topics: Anti-Bacterial Agents; Area Under Curve; Chromatography, High Pressure Liquid; Daptomycin; Humans; Infusions, Intravenous; Male; Methicillin Resistance; Middle Aged; Obesity, Morbid; Pseudomonas Infections; Renal Insufficiency; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Clearance of vancomycin during high-efficiency hemodialysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Cellulose; Female; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; Renal Dialysis; Renal Insufficiency; Vancomycin | 2006 |
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Prospective Studies; Renal Insufficiency; Safety; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
Hemolytic-uremic syndrome and myocardial dysfunction in a 9-month-old boy.
Topics: Anemia; Anti-Bacterial Agents; Cardiomyopathies; Cardiotonic Agents; Dopamine; Electrocardiography; Hemolytic-Uremic Syndrome; Humans; Infant; Intubation, Intratracheal; Male; Meropenem; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Oliguria; Peritoneal Dialysis; Renal Dialysis; Renal Insufficiency; Respiration, Artificial; Thienamycins; Vancomycin | 2007 |
Impact of vancomycin therapeutic drug monitoring on patient care.
Topics: Adolescent; Adult; Cohort Studies; Drug Monitoring; Female; Hospitals, Teaching; Humans; Indiana; Length of Stay; Male; Middle Aged; Pharmacists; Pharmacy Service, Hospital; Prospective Studies; Renal Insufficiency; Treatment Outcome; Vancomycin | 1994 |
Assay of vancomycin by fluorescence polarisation immunoassay and EMIT in patients with renal failure.
Topics: Enzyme Multiplied Immunoassay Technique; Fluorescence Polarization Immunoassay; Humans; Renal Dialysis; Renal Insufficiency; Vancomycin | 1995 |
Falsely elevated serum vancomycin concentrations.
Topics: False Positive Reactions; Humans; Renal Dialysis; Renal Insufficiency; Vancomycin | 1996 |
Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Child; Drug Resistance, Microbial; Enterococcus; Gallbladder Diseases; Gram-Positive Bacterial Infections; Humans; Incidence; Liver Transplantation; Postoperative Complications; Renal Insufficiency; Respiratory Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 1998 |
Fluorescence polarization immunoassay: can it result in an overestimation of vancomycin in patients not suffering from renal failure?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Enzyme Multiplied Immunoassay Technique; Female; Fluorescence Polarization Immunoassay; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Treatment Outcome; Vancomycin | 2001 |
[Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Pefloxacin; Piperacillin; Prospective Studies; Renal Insufficiency; Vancomycin | 1992 |
[Monitoring of plasma levels of vancomycin: indications, advantages, and other considerations].
Topics: Age Factors; Drug Monitoring; Humans; Renal Insufficiency; Vancomycin | 1992 |